東駿控股(08383.HK)中期淨溢利約650萬令吉
格隆匯4月12日丨東駿控股(08383.HK)公佈,截至2022年2月28日止六個月,集團總收入約為1.333億令吉,較2021年同期增加約4.0%;毛利約為2540萬令吉,較2021年同期減少約0.7%;集團錄得淨溢利約650萬令吉。
收入增加乃主要由於主要客户的需求增加,導致包裝及插頁銷售增加所致,但部分由説明書銷售的減少所抵銷。五大客户所貢獻的收入由截至2021年2月28日止六個月的約1.013億令吉減至截至2022年2月28日止六個月的9140萬令吉,分別佔同期總收入的79.0%及68.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.